Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Infectious disease > HIV/AIDS > Treatment: antiretroviral drugs

Reproductive & sexual health > HIV/AIDS > Treatment: antiretroviral drugs

Published:

2 February 2018

Authors:

Cruciani M, Martí-Carvajal AJ, Mengoli C, Serpelloni G, Bovo C, Moyle G

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Cruciani M, Martí-Carvajal AJ, Mengoli C, Serpelloni G, Bovo C, Moyle G. Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD009390. DOI: 10.1002/14651858.CD009390.pub2